Literature DB >> 23792672

Redox regulation of insulin sensitivity due to enhanced fatty acid utilization in the mitochondria.

Paul M Rindler1, Clair L Crewe, Jolyn Fernandes, Michael Kinter, Luke I Szweda.   

Abstract

Obesity enhances the risk for the development of type 2 diabetes and cardiovascular disease. Loss in insulin sensitivity and diminished ability of muscle to take up and use glucose are characteristics of type 2 diabetes. Paradoxically, regulatory mechanisms that promote utilization of fatty acids appear to initiate diet-induced insulin insensitivity. In this review, we discuss recent findings implicating increased mitochondrial production of the prooxidant H2O2 due to enhanced utilization of fatty acids, as a signal to diminish reliance on glucose and its metabolites for energy. In the short term, the ability to preferentially use fatty acids may be beneficial, promoting a metabolic shift that ensures use of available fat by skeletal muscle and heart while preventing intracellular glucose accumulation and toxicity. However, with prolonged consumption of high dietary fat and ensuing obesity, the near exclusive dependence on fatty acid oxidation for production of energy by the mitochondria drives insulin resistance, diabetes, and cardiovascular disease.

Entities:  

Keywords:  insulin signaling; metabolic flexibility; mitochondria; obesity; redox signaling

Mesh:

Substances:

Year:  2013        PMID: 23792672     DOI: 10.1152/ajpheart.00799.2012

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  19 in total

1.  Lysine Acetylation Activates Mitochondrial Aconitase in the Heart.

Authors:  Jolyn Fernandes; Alexis Weddle; Caroline S Kinter; Kenneth M Humphries; Timothy Mather; Luke I Szweda; Michael Kinter
Journal:  Biochemistry       Date:  2015-06-19       Impact factor: 3.162

Review 2.  Muscle and adipose tissue insulin resistance: malady without mechanism?

Authors:  Daniel J Fazakerley; James R Krycer; Alison L Kearney; Samantha L Hocking; David E James
Journal:  J Lipid Res       Date:  2018-07-27       Impact factor: 5.922

3.  Low cytochrome oxidase 4I1 links mitochondrial dysfunction to obesity and type 2 diabetes in humans and mice.

Authors:  B Van der Schueren; R Vangoitsenhoven; B Geeraert; D De Keyzer; M Hulsmans; M Lannoo; H J Huber; C Mathieu; P Holvoet
Journal:  Int J Obes (Lond)       Date:  2015-04-14       Impact factor: 5.095

Review 4.  Protective mechanisms of mitochondria and heart function in diabetes.

Authors:  Miguel A Aon; Carlo G Tocchetti; Niraj Bhatt; Nazareno Paolocci; Sonia Cortassa
Journal:  Antioxid Redox Signal       Date:  2015-03-31       Impact factor: 8.401

Review 5.  The mitochondria in diabetic heart failure: from pathogenesis to therapeutic promise.

Authors:  Joel D Schilling
Journal:  Antioxid Redox Signal       Date:  2015-04-15       Impact factor: 8.401

6.  Coenzyme A-mediated degradation of pyruvate dehydrogenase kinase 4 promotes cardiac metabolic flexibility after high-fat feeding in mice.

Authors:  Christopher Schafer; Zachary T Young; Catherine A Makarewich; Abdallah Elnwasany; Caroline Kinter; Michael Kinter; Luke I Szweda
Journal:  J Biol Chem       Date:  2018-03-14       Impact factor: 5.157

7.  Restoring redox balance enhances contractility in heart trabeculae from type 2 diabetic rats exposed to high glucose.

Authors:  Niraj M Bhatt; Miguel A Aon; Carlo G Tocchetti; Xiaoxu Shen; Swati Dey; Genaro Ramirez-Correa; Brian O'Rourke; Wei Dong Gao; Sonia Cortassa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-12-05       Impact factor: 4.733

8.  Exposure to Static Magnetic and Electric Fields Treats Type 2 Diabetes.

Authors:  Calvin S Carter; Sunny C Huang; Charles C Searby; Benjamin Cassaidy; Michael J Miller; Wojciech J Grzesik; Ted B Piorczynski; Thomas K Pak; Susan A Walsh; Michael Acevedo; Qihong Zhang; Kranti A Mapuskar; Ginger L Milne; Antentor O Hinton; Deng-Fu Guo; Robert Weiss; Kyle Bradberry; Eric B Taylor; Adam J Rauckhorst; David W Dick; Vamsidhar Akurathi; Kelly C Falls-Hubert; Brett A Wagner; Walter A Carter; Kai Wang; Andrew W Norris; Kamal Rahmouni; Garry R Buettner; Jason M Hansen; Douglas R Spitz; E Dale Abel; Val C Sheffield
Journal:  Cell Metab       Date:  2020-10-06       Impact factor: 27.287

9.  17β-Estradiol Directly Lowers Mitochondrial Membrane Microviscosity and Improves Bioenergetic Function in Skeletal Muscle.

Authors:  Maria J Torres; Kim A Kew; Terence E Ryan; Edward Ross Pennington; Chien-Te Lin; Katherine A Buddo; Amy M Fix; Cheryl A Smith; Laura A Gilliam; Sira Karvinen; Dawn A Lowe; Espen E Spangenburg; Tonya N Zeczycki; Saame Raza Shaikh; P Darrell Neufer
Journal:  Cell Metab       Date:  2017-11-02       Impact factor: 27.287

10.  Breast cancer-associated skeletal muscle mitochondrial dysfunction and lipid accumulation is reversed by PPARG.

Authors:  Hannah E Wilson; David A Stanton; Stephanie Rellick; Werner Geldenhuys; Emidio E Pistilli
Journal:  Am J Physiol Cell Physiol       Date:  2021-01-13       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.